Table 1.
Summary of the characteristics of the included studies.
| Study | Sample | Age | Outcomes assessed | Number of patients with a history of CVD | Follow-up |
|---|---|---|---|---|---|
| Chen et al 2020 [10] | 113 | 68 years old (37−88) | Mortality Severity Complications (heart failure, kidney failure, sepsis) |
10 | In Hospital |
| Grasselli et al 2020 [11] | 1591 | 63 years old (56−70) | Mortality Severity Complications (heart failure, kidney failure, sepsis) |
109 | 30 days |
| Guan et al 2020 [12] | 1099 | 47 years old (33−67) | Mortality Severity Complications (heart failure, kidney failure, sepsis) |
15 | In Hospital |
| Wang et al 2020 [13] | 107 | 51 years old (36−65) | Mortality Severity Evidence of co-infection Effectiveness of pharmacological therapy |
6 | 30 days |
| Yang et al 2020 [14] | 52 | 59.7 years (46.2−86.6) | Mortality | 7 | In Hospital |
| Zhao et al 2020 [15] | 91 | 46 years old (30−68) | Mortality Severity Effectiveness of pharmacological therapy Need for mechanical ventilation Complications (heart failure, kidney failure, sepsis) |
7 | In Hospital |
| Zhou et al 2020 [16] | 191 | 56 years old (46−67) | Mortality Severity Complications (heart failure, kidney failure, sepsis) |
44 | 30 days |